LSTA Return on Tangible Equity | LISATA THERAPEUTICS, INC.

LISATA THERAPEUTICS, INC. (LSTA) Return on Tangible Equity

2026-06-30: Return Tang Equity -1188.04%.
2026-03-31: Return Tang Equity -417.90%.
2025-12-31: Return Tang Equity -211.51%.
2025-09-30: Return Tang Equity -178.48%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-1188.04%
2026-03-31	-417.90%
2025-12-31	-211.51%
2025-09-30	-178.48%
2025-06-30	-136.54%
2025-03-31	-106.27%
2024-12-31	-89.36%
2024-09-30	-78.36%
2024-06-30	-67.95%
2024-03-31	-56.11%
2023-12-31	-50.99%
2023-09-30	-47.01%
2023-06-30	-105.79%
2023-03-31	-104.77%
2022-12-31	-91.55%
2022-09-30	-85.11%
2022-06-30	-32.60%
2022-03-31	-29.00%
2021-12-31	-32.22%
2021-09-30	-29.17%
2021-06-30	-25.59%
2021-03-31	-12.09%
2020-12-31	-34.95%
2020-09-30	-26.87%
2020-06-30	-29.42%
2020-03-31	-235.41%
2019-12-31	-166.37%
2019-09-30	-111.77%
2019-06-30	-80.21%
2019-03-31	-60.86%
2018-12-31	-56.63%
2018-09-30	-46.25%
2018-06-30	-42.69%
2018-03-31	76.32%
2017-12-31	55.60%
2017-09-30	44.59%
2017-06-30	35.25%
2017-03-31	304.94%
2016-12-31	735.95%
2016-09-30	-4714.15%
2016-06-30	1891.15%
2016-03-31	-1886.68%
2015-12-31	-586.08%
2015-09-30	786.47%
2015-06-30	-1950.81%
2015-03-31	271.33%
2014-12-31	384.94%
2014-09-30	567.78%
2014-06-30	-1856.40%
2014-03-31	-126.46%
2013-12-31	-103.81%
2013-09-30	-397.46%
2013-06-30	-505.58%
2013-03-31	-1338.00%
2012-12-31	-709.49%
2012-09-30	-254.28%
2012-06-30	-274.04%
2012-03-31	-161.25%
2011-12-31	-131.13%
2011-09-30	-83.72%
2011-06-30	-134.79%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-211.51%
2024-12-31	-89.36%
2023-12-31	-50.99%
2022-12-31	-94.70%
2021-12-31	-33.12%
2020-12-31	-35.17%
2019-12-31	-168.43%
2018-12-31	-56.92%
2017-12-31	55.79%
2016-12-31	735.95%
2015-12-31	-586.08%
2014-12-31	384.94%
2013-12-31	-103.81%
2012-12-31	-709.49%
2011-12-31	-131.58%
2010-12-31	-107.61%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Vistagen Therapeutics, Inc. (VTGN)	United States	$0.013B	-0.14
MUSTANG BIO, INC. (MBIO)	United States	$0.013B
BullFrog AI Holdings, Inc. (BFRG)	United States	$0.014B
AEON Biopharma, Inc. (AEON)	United States	$0.013B	-0.36
Vyome Holdings, Inc (HIND)	United States	$0.014B	-1.38
Tvardi Therapeutics, Inc. (TVRD)	United States	$0.014B
Tempest Therapeutics, Inc. (TPST)	United States	$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)	United States	$0.012B	-0.60
ACTUATE THERAPEUTICS, INC. (ACTU)	United States	$0.015B
BIOVIE INC. (BIVI)	United States	$0.012B